174 related articles for article (PubMed ID: 35481270)
1. Transcriptome and Proteome Analysis in LUHMES Cells Overexpressing Alpha-Synuclein.
Höllerhage M; Stepath M; Kohl M; Pfeiffer K; Chua OWH; Duan L; Hopfner F; Eisenacher M; Marcus K; Höglinger GU
Front Neurol; 2022; 13():787059. PubMed ID: 35481270
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Phosphoproteomic Analysis in Alpha-Synuclein Transgenic Mice Reveals the Involvement of Aberrant p25/Cdk5 Signaling in Early-stage Parkinson's Disease.
He F; Qi G; Zhang Q; Cai H; Li T; Li M; Zhang Q; Chen J; Ming J; Tian B; Zhang P
Cell Mol Neurobiol; 2020 Aug; 40(6):897-909. PubMed ID: 32016637
[TBL] [Abstract][Full Text] [Related]
3. Neuronal Differentiation of LUHMES Cells Induces Substantial Changes of the Proteome.
Tüshaus J; Kataka ES; Zaucha J; Frishman D; Müller SA; Lichtenthaler SF
Proteomics; 2021 Jan; 21(1):e2000174. PubMed ID: 32951307
[TBL] [Abstract][Full Text] [Related]
4. Cell-based assays for Parkinson's disease using differentiated human LUHMES cells.
Zhang XM; Yin M; Zhang MH
Acta Pharmacol Sin; 2014 Jul; 35(7):945-56. PubMed ID: 24989254
[TBL] [Abstract][Full Text] [Related]
5. Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons.
Richter F; Gao F; Medvedeva V; Lee P; Bove N; Fleming SM; Michaud M; Lemesre V; Patassini S; De La Rosa K; Mulligan CK; Sioshansi PC; Zhu C; Coppola G; Bordet T; Pruss RM; Chesselet MF
Neurobiol Dis; 2014 Sep; 69():263-75. PubMed ID: 24844147
[TBL] [Abstract][Full Text] [Related]
6. A53T-alpha-synuclein-overexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAP.
Kurz A; May C; Schmidt O; Müller T; Stephan C; Meyer HE; Gispert S; Auburger G; Marcus K
J Neural Transm (Vienna); 2012 Mar; 119(3):297-312. PubMed ID: 21960009
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive miRNome-Wide Profiling in a Neuronal Cell Model of Synucleinopathy Implies Involvement of Cell Cycle Genes.
Findeiss E; Schwarz SC; Evsyukov V; Rösler TW; Höllerhage M; Chakroun T; Nykänen NP; Shen Y; Wurst W; Kohl M; Tost J; Höglinger GU
Front Cell Dev Biol; 2021; 9():561086. PubMed ID: 33748099
[TBL] [Abstract][Full Text] [Related]
8. Quantitative proteomics in A30P*A53T α-synuclein transgenic mice reveals upregulation of Sel1l.
Yan J; Zhang P; Jiao F; Wang Q; He F; Zhang Q; Zhang Z; Lv Z; Peng X; Cai H; Tian B
PLoS One; 2017; 12(8):e0182092. PubMed ID: 28771510
[TBL] [Abstract][Full Text] [Related]
9. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
[TBL] [Abstract][Full Text] [Related]
10. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD.
Miller RM; Kiser GL; Kaysser-Kranich T; Casaceli C; Colla E; Lee MK; Palaniappan C; Federoff HJ
Exp Neurol; 2007 Mar; 204(1):421-32. PubMed ID: 17254569
[TBL] [Abstract][Full Text] [Related]
11. Proteome response to the panneural expression of human wild-type alpha-synuclein: a Drosophila model of Parkinson's disease.
Xun Z; Kaufman TC; Clemmer DE
J Proteome Res; 2008 Sep; 7(9):3911-21. PubMed ID: 18683964
[TBL] [Abstract][Full Text] [Related]
12. Expression of α-synuclein is regulated in a neuronal cell type-dependent manner.
Taguchi K; Watanabe Y; Tsujimura A; Tanaka M
Anat Sci Int; 2019 Jan; 94(1):11-22. PubMed ID: 30362073
[TBL] [Abstract][Full Text] [Related]
13. DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson's disease.
Arkan S; Ljungberg M; Kirik D; Hansen C
Neurobiol Dis; 2021 Oct; 158():105477. PubMed ID: 34390836
[TBL] [Abstract][Full Text] [Related]
14. Expression signatures of long non-coding RNA in the substantia nigra of pre-symptomatic mouse model of Parkinson's disease.
Jiao F; Wang Q; Zhang P; Bu L; Yan J; Tian B
Behav Brain Res; 2017 Jul; 331():123-130. PubMed ID: 28476570
[TBL] [Abstract][Full Text] [Related]
15. Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons.
Caudal D; Alvarsson A; Björklund A; Svenningsson P
Exp Neurol; 2015 Nov; 273():243-52. PubMed ID: 26363495
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
18. Fas-associated factor 1 induces the accumulation of α-synuclein through autophagic suppression in dopaminergic neurons.
Kim BS; Jang T; Yoo SE; Lee JM; Kim E
FASEB J; 2021 Apr; 35(4):e21363. PubMed ID: 33749937
[TBL] [Abstract][Full Text] [Related]
19. Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T α-synuclein.
Goulding SR; Sullivan AM; O'Keeffe GW; Collins LM
Parkinsonism Relat Disord; 2019 Jul; 64():194-201. PubMed ID: 31000327
[TBL] [Abstract][Full Text] [Related]
20. Altered machinery of protein synthesis is region- and stage-dependent and is associated with α-synuclein oligomers in Parkinson's disease.
Garcia-Esparcia P; Hernández-Ortega K; Koneti A; Gil L; Delgado-Morales R; Castaño E; Carmona M; Ferrer I
Acta Neuropathol Commun; 2015 Dec; 3():76. PubMed ID: 26621506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
